Media Center
Press Releases
2023
Astex Pharmaceuticals Announce Key Data Presentations at the 36th EORTC-NCI-AACR Symposium
21 October 2024/by webadminAstex Pharmaceuticals Announce Key Data Presentations at the American Association For Cancer Research (AACR) 2024 Annual Meeting
3 April 2024/by webadminThird Success from Astex Drug Discovery Pharma Collaboration and Licence Agreements as AstraZeneca Receives US Marketing Approval for Cancer Drug Truqap (capivasertib)
20 November 2023/by webadminAstex CSO David Rees Honoured as a Hero of Chemistry by the American Chemical Society
13 October 2023/by webadminAstex Expands Drug Discovery Collaboration With MSD
8 August 2023/by webadminAstex and Cardiff University Medicines Discovery Institute Announce New Drug Discovery Collaboration on Neurodegenerative Diseases
13 February 2023/by webadminAstex Co-founder and CEO Harren Jhoti Awarded OBE in the King’s New Year Honours
31 December 2022/by webadminBritish Company Behind Groundbreaking Breast Cancer Treatment
7 June 2019/by webadminAstex Pharmaceuticals Celebrates as Second New Cancer Drug Receives US Marketing Approval
12 April 2019/by webadminAstex’s Harren Jhoti Made Fellow of the Royal Society
9 May 2018/by webadminAstex Continues to Deliver in Oncology as Erdafitinib, a Potential New Treatment for Metastatic Urothelial Cancer, Receives US FDA Breakthrough Therapy Designation
15 March 2018/by webadminHarren Jhoti Receives Lifetime Achievement Award from the UK BioIndustry Association
26 January 2018/by webadminOtsuka Signs Statement of Support for Women’s Empowerment Principles
19 January 2018/by Peggy BickertonAstex Pharmaceuticals Celebrates as Cancer Drug Receives Marketing Approval in Europe
24 August 2017/by Peggy BickertonCambridge-based Astex Pharmaceuticals Celebrates as Cancer Drug Receives US Marketing Approval
13 March 2017/by Peggy BickertonSelected past releases are archived for your reference.
